237 related articles for article (PubMed ID: 29794203)
1. Clinical Pharmacology of Oral Maintenance Therapies for Obstructive Lung Diseases.
Pleasants RA
Respir Care; 2018 Jun; 63(6):671-689. PubMed ID: 29794203
[TBL] [Abstract][Full Text] [Related]
2. Systemic Medications in Chronic Obstructive Pulmonary Disease: Use and Outcomes.
Roche N
Thorac Surg Clin; 2021 May; 31(2):97-106. PubMed ID: 33926676
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic responses in asthma and COPD. Bronchodilators.
Donohue JF
Chest; 2004 Aug; 126(2 Suppl):125S-137S; discussion 159S-161S. PubMed ID: 15302773
[TBL] [Abstract][Full Text] [Related]
4. The preclinical pharmacology of roflumilast--a selective, oral phosphodiesterase 4 inhibitor in development for chronic obstructive pulmonary disease.
Hatzelmann A; Morcillo EJ; Lungarella G; Adnot S; Sanjar S; Beume R; Schudt C; Tenor H
Pulm Pharmacol Ther; 2010 Aug; 23(4):235-56. PubMed ID: 20381629
[TBL] [Abstract][Full Text] [Related]
5. [Pharmacological treatment of COPD and future of anti-inflammatory therapy].
Watz H; Bitter-Suermann S; Kanniess F; Magnussen H
Med Klin (Munich); 2006 Apr; 101(4):283-92. PubMed ID: 16607484
[TBL] [Abstract][Full Text] [Related]
6. Theophylline in chronic obstructive pulmonary disease: new horizons.
Barnes PJ
Proc Am Thorac Soc; 2005; 2(4):334-9; discussion 340-1. PubMed ID: 16267358
[TBL] [Abstract][Full Text] [Related]
7. Xanthines and Phosphodiesterase Inhibitors.
Spina D; Page CP
Handb Exp Pharmacol; 2017; 237():63-91. PubMed ID: 27844172
[TBL] [Abstract][Full Text] [Related]
8. Cilomilast.
Schachter EN
Drugs Today (Barc); 2006 Apr; 42(4):237-47. PubMed ID: 16703120
[TBL] [Abstract][Full Text] [Related]
9. Cardiac effects of current treatments of chronic obstructive pulmonary disease.
Lahousse L; Verhamme KM; Stricker BH; Brusselle GG
Lancet Respir Med; 2016 Feb; 4(2):149-64. PubMed ID: 26794033
[TBL] [Abstract][Full Text] [Related]
10. Treatment of chronic obstructive pulmonary disease with roflumilast, a new phosphodiesterase 4 inhibitor.
Gross NJ; Giembycz MA; Rennard SI
COPD; 2010 Apr; 7(2):141-53. PubMed ID: 20397815
[TBL] [Abstract][Full Text] [Related]
11. Novel anti-inflammatory agents in COPD: targeting lung and systemic inflammation.
Loukides S; Bartziokas K; Vestbo J; Singh D
Curr Drug Targets; 2013 Feb; 14(2):235-45. PubMed ID: 23256720
[TBL] [Abstract][Full Text] [Related]
12. [Medical maintenance treatment of chronic obstructive pulmonary disease (COPD)].
Kerstjens HA; Postma DS
Ned Tijdschr Geneeskd; 2002 Aug; 146(35):1631-5. PubMed ID: 12233157
[TBL] [Abstract][Full Text] [Related]
13. Impact of Mucolytic Agents on COPD Exacerbations: A Pair-wise and Network Meta-analysis.
Cazzola M; Rogliani P; Calzetta L; Hanania NA; Matera MG
COPD; 2017 Oct; 14(5):552-563. PubMed ID: 28753070
[TBL] [Abstract][Full Text] [Related]
14. Theophylline for chronic obstructive pulmonary disease?....Time to move on.
Rabe KF; Hiemstra PS
Am J Respir Crit Care Med; 2010 Oct; 182(7):868-9. PubMed ID: 20884941
[No Abstract] [Full Text] [Related]
15. [New treatments for chronic obstructive pulmonary disease].
Miravitlles M
Med Clin (Barc); 2005 Jun; 125(2):65-74. PubMed ID: 15970187
[TBL] [Abstract][Full Text] [Related]
16. Systemic Medications in Chronic Obstructive Pulmonary Disease: Use and Outcomes.
Roche N
Clin Chest Med; 2020 Sep; 41(3):485-494. PubMed ID: 32800201
[TBL] [Abstract][Full Text] [Related]
17. The evidence for the use of oral mucolytic agents in chronic obstructive pulmonary disease (COPD).
Davies L; Calverley PM
Br Med Bull; 2010; 93():217-27. PubMed ID: 20031934
[TBL] [Abstract][Full Text] [Related]
18. [Effects of mucolytic agents and macrolides in the treatment of COPD].
Yamaya M
Nihon Rinsho; 2016 May; 74(5):833-8. PubMed ID: 27254955
[TBL] [Abstract][Full Text] [Related]
19. [Theophylline, a new look to an old drug].
Morfín Maciel BM; Castillo Morfín BM
Rev Alerg Mex; 2010; 57(4):112-22. PubMed ID: 21255523
[TBL] [Abstract][Full Text] [Related]
20. Macrolides: a promising pharmacologic therapy for chronic obstructive pulmonary disease.
Qiu S; Zhong X
Ther Adv Respir Dis; 2017 Mar; 11(3):147-155. PubMed ID: 28030992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
